In 2023, the trade exchange (includes international purchases and sales) of Prepared Preserved Meat or Offal Bovines (Exc Sausages and Similar Products .; Preparations Homogenised for Infant or for Uses Dietary Upgraded for Retail in Containers of <= 250 G.; Preparations of Liver Extracts and Gravies) was US$18.9M.
In 2023, the states with the most international sales in Prepared Preserved Meat or Offal Bovines (Exc Sausages and Similar Products .; Preparations Homogenised for Infant or for Uses Dietary Upgraded for Retail in Containers of <= 250 G.; Preparations of Liver Extracts and Gravies) were Nuevo León (US$2.65M).
The states with the most international purchases in 2023 were Ciudad de México (US$6.83M), Estado de México (US$1.87M), Nuevo León (US$924k), and Baja California (US$329k).
In 2023, the main commercial destinations of Prepared Preserved Meat or Offal Bovines (Exc Sausages and Similar Products .; Preparations Homogenised for Infant or for Uses Dietary Upgraded for Retail in Containers of <= 250 G.; Preparations of Liver Extracts and Gravies) were United States (US$2.65M).
The main commercial origins of Prepared Preserved Meat or Offal Bovines (Exc Sausages and Similar Products .; Preparations Homogenised for Infant or for Uses Dietary Upgraded for Retail in Containers of <= 250 G.; Preparations of Liver Extracts and Gravies) in 2023 were United States (US$4.47M), Nicaragua (US$2.74M), Panama (US$1.48M), Brazil (US$578k), and Canada (US$389k).
In the global context, the main exporting countries of Prepared Preserved Meat or Offal Bovines (Exc Sausages and Similar Products .; Preparations Homogenised for Infant or for Uses Dietary Upgraded for Retail in Containers of <= 250 G.; Preparations of Liver Extracts and Gravies) in 2022 were Brazil (US$777M), United States (US$311M), and Germany (US$217M). In the same year, the main importing countries of Prepared Preserved Meat or Offal Bovines (Exc Sausages and Similar Products .; Preparations Homogenised for Infant or for Uses Dietary Upgraded for Retail in Containers of <= 250 G.; Preparations of Liver Extracts and Gravies) were United States (US$702M), United Kingdom (US$322M), and Canada (US$208M).